Skip to main content
Erschienen in: Pathology & Oncology Research 3/2008

01.09.2008 | Brief Communication

Prolonged Survival Using Anti-CD20 Combined Chemotherapy in Primary Prostatic Intravascular Large B-cell Lymphoma

verfasst von: Judit Csomor, Ilona Kaszás, Balázs Kollár, László Pajor, Zsolt Egyházi, Sándor Fekete, Miklós Egyed, Botond Timár

Erschienen in: Pathology & Oncology Research | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Here we report a case of a 73-year-old man with primary intravascular large B-cell lymphoma localized to the prostate. Total prostatectomy was performed due to a benign adenoma suggested by ultrasonography. The diagnosis of IVLBL was obtained incidentally from the prostatectomy specimen. Eight months after the initial R-CHOP chemotherapy a relapse was detected in the left inguinal lymph node, where histologic examination revealed common diffuse large B-cell lymphoma with minimal intravascular component. The second complete remission was achieved by R-IEV therapy. Five months later a second relapse occurred and the patient died in the widespread disease and pneumonia. Primary prostate IVLBL is extremely uncommon; to date only four cases have been described. This is a well documented case, where we also confirmed that the initial primary IVLBL and the secondary lymph node involvement are clonally related. Successful treatment depends on early diagnosis of IVLBL, aggressive chemotherapy and the fact that IVLBL should be considered as a generalized disease in spite of negative staging results.
Literatur
1.
Zurück zum Zitat Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds) (2001) World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds) (2001) World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon
2.
Zurück zum Zitat Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A et al (2004) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 127(2):173–183CrossRefPubMed Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A et al (2004) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 127(2):173–183CrossRefPubMed
3.
Zurück zum Zitat Bostwick DG, Iczkowski KA, Amin MB, Discigil G, Osborne B (1998) Malignant lymphoma involving the prostate: report of 62 cases. Cancer 83(4):732–738CrossRefPubMed Bostwick DG, Iczkowski KA, Amin MB, Discigil G, Osborne B (1998) Malignant lymphoma involving the prostate: report of 62 cases. Cancer 83(4):732–738CrossRefPubMed
4.
Zurück zum Zitat Chu PG, Huang Q, Weiss LM (2005) Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases. Am J Surg Pathol 29(5):693–699CrossRefPubMed Chu PG, Huang Q, Weiss LM (2005) Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases. Am J Surg Pathol 29(5):693–699CrossRefPubMed
5.
Zurück zum Zitat Yin XR, Liu H, Chen HQ (2005) Intravascular lymphomatosis of the prostate gland. Zhonghua Bing Li Xue Za Zhi 34(3):189–190, ChinesePubMed Yin XR, Liu H, Chen HQ (2005) Intravascular lymphomatosis of the prostate gland. Zhonghua Bing Li Xue Za Zhi 34(3):189–190, ChinesePubMed
6.
Zurück zum Zitat Alfaro J, Espinoza A, Manŕiquez M, Moyano L, González N, Larrondo M, Figueroa G (2004) Intravascular lymphoma treated with anti CD20 monoclonal antibodies. Report of one case. Rev Med Chil 132(11):1403–1406, SpanishPubMed Alfaro J, Espinoza A, Manŕiquez M, Moyano L, González N, Larrondo M, Figueroa G (2004) Intravascular lymphoma treated with anti CD20 monoclonal antibodies. Report of one case. Rev Med Chil 132(11):1403–1406, SpanishPubMed
7.
Zurück zum Zitat Quintini G, Barbera V, Franco V, Florena AM, Spadola V, Mariani G (2003) Uncommon presentations of non-Hodgkin’s lymphoma: case 1. Intravascular large B-cell lymphoma: diagnosis on prostate biopsy. J Clin Oncol 21(3):564–565CrossRefPubMed Quintini G, Barbera V, Franco V, Florena AM, Spadola V, Mariani G (2003) Uncommon presentations of non-Hodgkin’s lymphoma: case 1. Intravascular large B-cell lymphoma: diagnosis on prostate biopsy. J Clin Oncol 21(3):564–565CrossRefPubMed
8.
Zurück zum Zitat Chim CS, Loong F (2002) Intravascular lymphomatosis of the prostate gland. Br J Haematol 119(1):2CrossRefPubMed Chim CS, Loong F (2002) Intravascular lymphomatosis of the prostate gland. Br J Haematol 119(1):2CrossRefPubMed
9.
Zurück zum Zitat Ponzoni M, Arrigoni G, Gould VE, Del Curto B, Maggioni M, Scapinello A et al (2000) Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 31(2):220–226CrossRefPubMed Ponzoni M, Arrigoni G, Gould VE, Del Curto B, Maggioni M, Scapinello A et al (2000) Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 31(2):220–226CrossRefPubMed
10.
Zurück zum Zitat Kishi Y, Kami M, Kusumi E, Mineyama T, Kato D, Hamaki T et al (2004) Prostatic acid phosphatase: a possible diagnostic marker of intravascular large B-cell lymphoma. Haematologica 89(5):ECR13PubMed Kishi Y, Kami M, Kusumi E, Mineyama T, Kato D, Hamaki T et al (2004) Prostatic acid phosphatase: a possible diagnostic marker of intravascular large B-cell lymphoma. Haematologica 89(5):ECR13PubMed
11.
Zurück zum Zitat Odawara J, Asada N, Aoki T, Yamakura M, Takeuchi M, Ohuchi T et al (2007) 18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma. Br J Haematol 136(5):684CrossRefPubMed Odawara J, Asada N, Aoki T, Yamakura M, Takeuchi M, Ohuchi T et al (2007) 18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma. Br J Haematol 136(5):684CrossRefPubMed
12.
Zurück zum Zitat Bouzani M, Karmiris T, Rontogianni D, Delimpassi S, Apostolidis J, Mpakiri M et al (2006) Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases treated with anthracycline-based immunochemotherapy. Oncologist 11(8):923–928CrossRefPubMed Bouzani M, Karmiris T, Rontogianni D, Delimpassi S, Apostolidis J, Mpakiri M et al (2006) Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases treated with anthracycline-based immunochemotherapy. Oncologist 11(8):923–928CrossRefPubMed
13.
Zurück zum Zitat Ohno T, Sakamoto T, Mizumoto C, Miyoshi T, Ueda M, Takeoka T et al. (2006) Leukemic and meningeal relapse of CD5+ intravascular large B-cell lymphoma with down-modulation of CD20 after rituximab therapy. Int J Hematol 84(1):74–78CrossRefPubMed Ohno T, Sakamoto T, Mizumoto C, Miyoshi T, Ueda M, Takeoka T et al. (2006) Leukemic and meningeal relapse of CD5+ intravascular large B-cell lymphoma with down-modulation of CD20 after rituximab therapy. Int J Hematol 84(1):74–78CrossRefPubMed
Metadaten
Titel
Prolonged Survival Using Anti-CD20 Combined Chemotherapy in Primary Prostatic Intravascular Large B-cell Lymphoma
verfasst von
Judit Csomor
Ilona Kaszás
Balázs Kollár
László Pajor
Zsolt Egyházi
Sándor Fekete
Miklós Egyed
Botond Timár
Publikationsdatum
01.09.2008
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 3/2008
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-008-9051-y

Weitere Artikel der Ausgabe 3/2008

Pathology & Oncology Research 3/2008 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.